Comparing Erector Spinae Plane (ESP) and Thoracic Paravertebral (TPV) Block Analgesic Effect After Elective VATS
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of the study is to compare two different locoregional techniques in VATS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable surgery
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 13, 2023
CompletedStudy Start
First participant enrolled
March 31, 2023
CompletedFirst Posted
Study publicly available on registry
April 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 28, 2025
February 1, 2025
1.8 years
January 13, 2023
February 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
cumulative dose of opioids at 24 and 48 h
by using a PCA we will see how many times the patient asked for analgesia
48 hours
Secondary Outcomes (9)
Pain scores at 4h, 8h, 24h, 48h via numeric rating scale (NRS) at rest and during cough
48 hours
Hypotension
48 hours
Cardio-pulmonary complications
48 hours
Procedure time and complications
48 hours
Need for anti-nausea medication (dosage, doses and time points)
48 hours
- +4 more secondary outcomes
Study Arms (2)
US-guided ESP block + sham US-guided TPV block
EXPERIMENTALESP block will be performed with local anesthetic under US guide; instead TPV block with physiological solution
sham US-guided ESP block + US-guided TPV block
SHAM COMPARATORESP block will be performed with physiological solution under US guide; instead TPV block with local anesthetic
Interventions
US guided ESP infiltration (saline solution vs Ropivacaine 0.375% according to randomization): unilateral injection of 0,4 ml kg -1 (ideal weight)2 under US guidance between the deep fascia of erector spinae muscle and the two transverse processes at the level of the 5th thoracic vertebrae. Duration approximately 10-15 minutes
Eligibility Criteria
You may qualify if:
- patients over 18 year of age undergoing elective VATS lung resection at ORBV
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Andrea Saporitolead
Study Sites (1)
Ente Ospedaliero Cantonale, Bellinzona
Bellinzona, Bellinzona, 6500, Switzerland
Study Officials
- STUDY CHAIR
Andrea Saporito, Anesth
Ente Ospedaliero Cantonale, Bellinzona
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Anesthesiology, PD DR MED
Study Record Dates
First Submitted
January 13, 2023
First Posted
April 4, 2023
Study Start
March 31, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
February 28, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share